Top Clinical Trials companies in South Korea by EBT Margin
South Korea
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
30.83%
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
| 2 |
23.52%
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
| 3 |
8.19%
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
| 4 |
5.34%
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
| 5 |
-3.69%
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
| 6 |
-4.04%
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
| 7 |
-12.36%
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
| 8 |
-12.99%
|
Dec. 31, 2023 | USD 1.01 | -3.22% |
|
South Korea |
|
| 9 |
-43.70%
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
| 10 |
-106.48%
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
| 11 |
-193.16%
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
| 12 |
-477.00%
|
Dec. 31, 2023 | USD 64.97 | -2.50% |
|
South Korea |
|
| 13 |
-652.07%
|
Dec. 31, 2023 | USD 17.88 | -1.83% |
|
South Korea |
|
| 14 |
-780.47%
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
| 15 |
-1,048.48%
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
| 16 |
-1,129.99%
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest EBT Margin ?
The Clinical Trials company in South Korea with the highest EBT Margin is Celltrion, Inc. (KSE: 068270.KS) at 30.83%.
-
Which Clinical Trials company in South Korea has the lowest EBT Margin ?
The Clinical Trials company in South Korea with the lowest EBT Margin is Genexine, Inc. (KOSDAQ: 095700.KQ) at -1,129.99%.
-
What are the top 10 Clinical Trials companies in South Korea by EBT Margin ?
The top 10 Clinical Trials companies in South Korea by EBT Margin are Celltrion, Inc., Boditech Med Inc., ST Pharm Co.,Ltd., Samjin Pharmaceuticals Co., Ltd., ALTEOGEN Inc., ABL Bio Inc., SK Biopharmaceuticals Co., Ltd., Enzychem Lifesciences Corporation, Anterogen.Co.,Ltd. and OliX Pharmaceuticals,Inc.
-
What are the bottom 10 Clinical Trials companies in South Korea by EBT Margin ?
The bottom 10 Clinical Trials companies in South Korea by EBT Margin are Genexine, Inc., CrystalGenomics, Inc., Gencurix Inc., Oscotec Inc., Peptron, Inc., GeneOne Life Science, Inc., OliX Pharmaceuticals,Inc, Anterogen.Co.,Ltd., Enzychem Lifesciences Corporation and SK Biopharmaceuticals Co., Ltd..
